About
Specialty Pharmaceuticals
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
7
As Collaborator
2
Total Enrollment
900
By Phase
PHASE3: 3PHASE1: 2PHASE1/PHASE2: 1PHASE2: 2
By Status
COMPLETED: 5TERMINATED: 2RECRUITING: 1AVAILABLE: 1
Clinical Trials Pipeline8 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05579327Collaborator
Withdrawal of Tiratricol Treatment in Males with Monocarboxylate Transporter 8 Deficiency (MCT8 Deficiency)
PHASE3Recruiting
16 participants
Started: Jul 21, 2023 · Completed: Jun 30, 2025
NCT04034355Lead Sponsor
Preventive Treatment of OxaLiplatin Induced peripherAl neuRopathy in Adjuvant Colorectal Cancer
PHASE3Terminated
301 participants
Started: Jan 7, 2019 · Completed: Aug 31, 2020
NCT03654729Lead Sponsor
Preventive Treatment of Oxaliplatin Induced Peripheral Neuropathy in Metastatic Colorectal Cancer (POLAR-M)
PHASE3Terminated
291 participants
Started: Nov 7, 2018 · Completed: Aug 31, 2020
NCT03430999Lead Sponsor
SUNCIST: A Study of Calmangafodipir in Healthy Japanese and Caucasian Subjects
PHASE1Completed
48 participants
Started: Nov 7, 2017 · Completed: Dec 18, 2017
NCT03177395Lead Sponsor
PP100-01 (Calmangafodipir) for Overdose of Paracetamol
PHASE1Completed
24 participants
Started: Jun 8, 2017 · Completed: Nov 8, 2018
Locations (1)
Headquarters
Stockholm, Sweden
Map
Loading map...